How many charts must a collaborating physician review for a Kentucky NP?

In Kentucky, a collaborating physician is not required to review a set number or percentage of a nurse practitioner’s charts. Instead, when an NP prescribes controlled substances under a CAPA-CS, the APRN and collaborating physician must meet to review the APRN’s reverse KASPER report at least quarterly in the first year and at least biannually in years two through four¹².

These collaboration meetings may include discussion of information from patient medical records to facilitate meaningful review, must be documented, and are subject to audit solely to confirm compliance¹. For nonscheduled legend drug prescribing under a CAPA-NS, the agreement must define the scope of prescriptive authority and the arrangement for collaboration and communication (which commonly includes physician chart review), but no chart-review quota is prescribed in these provisions³.